Mayo Clinic registers Phase 3 trial of DEKA TWIIST insulin pump in pregnant T1D patients
Mayo Clinic has registered a not yet recruiting Phase 3 trial testing the TWIIST insulin pump with Tidepool Loop in pregnant people with type 1 diabetes.
This week's update covers a single new registry entry for an automated insulin delivery study in pregnancy.
- A Phase 3 trial (NCT07808385) led by Mayo Clinic, with Icahn School of Medicine at Mount Sinai, University of Colorado Denver, and Stanford University as collaborators, is not yet recruiting. The study is designed to test how the system performs in pregnant people with pre-existing type 1 diabetes in the US, beginning as soon as pregnancy is confirmed and continuing through delivery and up to six weeks postpartum.1 The trial plans to enroll 32 participants (estimated)1 and lists an estimated start date of 2026-09.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.